liver disease
-
Sam Vanderpump’s Health Shocks Fans: What’s Next?
Sam Vanderpump, star of ‘Vanderpump Villa,’ reveals end-stage liver disease. The diagnosis raises questions about access to healthcare and early detection.
-
The Hidden Health Cost of Binge-Watching and Binge-Drinking
New research links episodic heavy drinking to triple the risk of advanced liver fibrosis, while the streaming era redefines ‘binge’ consumption habits.
-
Novo Nordisk to Acquire Akero Therapeutics for $5.2B, Targeting Breakthrough Liver Drug
Novo Nordisk has announced its acquisition of Akero Therapeutics for up to $5.2 billion, aiming to secure a promising liver disease treatment and strengthen its position in metabolic and cardiometabolic therapies.
-
Semaglutide Shows Promise in Treating Liver Disease MASH
A landmark phase 3 trial reveals semaglutide’s potential to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease affecting millions globally.
-
Wegovy Shows Promise in Treating Advanced Liver Disease, Study Finds
Clinical trials reveal Wegovy’s potential to treat metabolic dysfunction-associated steatohepatitis (MASH), reducing liver inflammation and fibrosis in patients.